Asunto(s)
Analgésicos Opioides/uso terapéutico , Tratamiento de Sustitución de Opiáceos , Trastornos Relacionados con Opioides/prevención & control , Analgésicos Opioides/provisión & distribución , COVID-19 , Canadá , Regulación Gubernamental , Necesidades y Demandas de Servicios de Salud , Humanos , Trastornos Relacionados con Opioides/tratamiento farmacológico , PandemiasAsunto(s)
Cannabis , Infecciones por Coronavirus , Sistemas Electrónicos de Liberación de Nicotina , Pandemias , Neumonía Viral , Vapeo , Adolescente , Betacoronavirus , COVID-19 , Canadá , Humanos , SARS-CoV-2RESUMEN
It is clear that exercise can be a source of great support for patients with major depressive disorder. However, it is important to recognize that several multifactorial and intersecting challenges are associated with exercise for this patient population. Group fitness programs for this patient population have the potential to be cost-effective while serving as an avenue of social interaction for participants. From an administrative perspective, it is challenging to balance satisfaction and adherence in group fitness programs targeting patients with major depressive disorder. This article presents a proposal that highlights what the challenges may look like in practice and discusses 3 strategies for improving satisfaction and adherence with a group fitness program: diagnosis and needs assessment, exercise diversity, and ongoing evaluation.
Asunto(s)
Trastorno Depresivo Mayor , Humanos , Trastorno Depresivo Mayor/terapia , Satisfacción del Paciente , Ejercicio Físico , Satisfacción Personal , Terapia por EjercicioRESUMEN
The aim of this study was to present a framework for clinicians to use when discussing electronic cigarette (e-cigarette) use and its association with pre-diabetes. A communication tool was designed using evidence-based strategies from the academic literature. A four-step framework is presented, which includes: step (1) helping patients to understand the association between e-cigarette use and pre-diabetes; step (2) the synergistic health impacts of e-cigarette use and pre-diabetes; step (3) management of diabetes-related lifestyle factors; and step (4) stages of change assessment related to e-cigarette reduction. This communication tool provides support for clinicians to discuss the risk of pre-diabetes associated with e-cigarette use. Moving forward, implementation and evaluation of this model are needed.